Infrastructure requirements (example) | Training requirements (example) | Test process time | MERS-CoV target population | MERS-CoV inhouse or LDTs (n) | MERS-CoV commercial tests (n) | |
Neutralisation | High/BSL-3 (reference laboratory) | High (advanced lab technician) | 5 days | Human, camel | >3 | 0 |
NAAT reference | High/BSL-3 (reference laboratory) | High (advanced lab technician) | 2–3 hours (1–2 hours prep) | Human, camel | >3 | >15 |
NAAT POC | Moderate/BSL-2 (district hospital) | Moderate (laboratory technician) | 1–2 hours | Human | 1 | 0 |
ELISA, IIFT | High to moderate (regional lab, district hospital) | Moderate (laboratory technician) | 3–4 hours | Human, camel | >5 | >5 |
RDTs | Low (clinic, health centre, field settings) | Low (nurse, healthcare worker) | <30 min | Human, camel | 3 | 2 |
BSL, biosafety level; IIFT, indirect immunofluorescence test; LDT, lab-developed test; MERS-CoV, Middle East respiratory syndrome-coronavirus ; NAAT, nucleic acid amplification test; POC, point of care; RDT, rapid diagnostic test.